| Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283) |
|---|
| 12/06/2001 | WO2001092991A2 Design of polyketide synthase genes |
| 12/05/2001 | EP1159278A2 Inhibitors of aspartyl protease |
| 12/05/2001 | EP1159237A1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use |
| 12/05/2001 | EP0835244B1 Diheterocyclic acrylonitriles as smooth muscle cell proliferation inhibitors |
| 12/04/2001 | US6326458 Continuous process for the manufacture of lactide and lactide polymers |
| 11/28/2001 | EP1158037A1 Fluoro-substitued alkenyl compounds, liquid crystal compositions, and liquid crystal display elements |
| 11/28/2001 | EP1157017A1 N-substituted imide derivatives with serotonergic activity |
| 11/28/2001 | CN1323795A 5-benzyloxy-trimethylene carbonate and its prepn. |
| 11/28/2001 | CN1323794A Novel hetero naphthenic benzcyclobutane and heterocyclo acryl benzcyclobutane compound, their prepn. method and pharmaceutical composites |
| 11/27/2001 | US6323227 Prodrugs |
| 11/22/2001 | WO2001087822A1 Novel phenyl-propargylether derivatives |
| 11/22/2001 | US20010044151 Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 11/21/2001 | EP1156043A2 Drugs that enhance synaptic responses mediated by ampa receptors |
| 11/21/2001 | EP1156042A1 Process for the preparation of glycerol carbonate |
| 11/21/2001 | EP1155015A1 Process for the production of tert-butyl (e)-(6-[2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl](4r,6s)-2,2-dimethyl[1,3]dioxan-4-yl)acetate |
| 11/21/2001 | EP1154992A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production |
| 11/20/2001 | US6319946 Inhibitors of aspartyl protease |
| 11/20/2001 | US6319944 Nmda nr2b antagonists; neurological and neurodegenerative diseases including pain, (and in particular neuropathic pain), epilepsy, stroke, anxiety, cerebral ischemia, muscular spasms, alzheimer's, huntington's and parkinson's diseases |
| 11/20/2001 | US6319930 Substituted dimeric compounds |
| 11/20/2001 | US6319570 Liquid crystalline compound, liquid crystal composition comprising the liquid crystal-line compound, and liquid crystal display device using the liquid crystal composition |
| 11/20/2001 | US6319428 Perfluorinated amide salts and their uses as ionic conducting materials |
| 11/15/2001 | WO2001085975A1 Process for the preparation of dihydroxy esters and derivatives thereof |
| 11/15/2001 | WO2001085713A1 Use of cyclic ketals as a fragrance |
| 11/15/2001 | DE10022417A1 Novel cyclic ketal compounds are useful as fragrances in cosmetics and cleaning preparations |
| 11/15/2001 | CA2677945A1 Process for the preparation of dihydroxy esters and derivatives thereof |
| 11/14/2001 | EP1021433B1 Method for producing natural diol-1,3 derivatives and corresponding natural 1,3-dioxane derivatives |
| 11/13/2001 | US6316679 Conversion to trimethylolalkane monocyclic formal and trimethylolalkane by transalcoholysis with alcohol in acid catalyst; acetal by-product |
| 11/13/2001 | US6316484 Pentafluorobenzenesulfonamides and analogs |
| 11/08/2001 | WO2001083571A2 Catalysts containing n-pyrrolyl substituted nitrogen donors |
| 11/08/2001 | CA2407692A1 Catalysts containing n-pyrrolyl substituted nitrogen donors |
| 11/07/2001 | EP1150937A1 Liquid crystalline trifluoro-substituted compounds |
| 11/07/2001 | CN1321144A Method for preparing trion-bis (oxime ether) derivs. and trion-mono and trio-bis (oxime ether) derivs. obtained therewith |
| 11/06/2001 | US6313294 Solvent-free amidation reaction of molten secondary alkylenediamine and ester to form tertiary amide; one step; noncatalytic reaction |
| 11/06/2001 | US6313293 Preparation of amides and quinazoline derivatives |
| 11/06/2001 | US6313173 Glyoxylic acid amides |
| 11/06/2001 | US6313160 Substituted heterocyclic compounds, method for preparing and compositions containing same |
| 11/06/2001 | US6313146 Calcium receptor-active molecules |
| 11/01/2001 | WO2001081276A2 Method for producing ketal and/or acetal |
| 10/31/2001 | EP1149885A1 Cyclohexane derivatives, liquid crystal compositions comprising the same and liquid crystal display devices |
| 10/31/2001 | EP1149087A1 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use |
| 10/31/2001 | EP1149069A1 Phenylglycine derivatives |
| 10/31/2001 | CN1320114A New derivatives of 6-(4-phenylbutoxy) hexylamine and process for producing salmeterol |
| 10/31/2001 | CN1319579A Use of 1,1-di(4-chlorophenyl-2,2,2-trichloroalcohol adduct |
| 10/31/2001 | CN1319578A Use of 1,1-di (4-chlorophenyl)-2,2,2-trichloroalcohol adduct |
| 10/30/2001 | US6310245 3-aminocarbonyl/3-aminothiocarbonyl-substituted 2-benzoyl-cyclohexan-1,3-diones with herbicidal effect |
| 10/30/2001 | US6310218 Melt crystallization purification of lactides |
| 10/30/2001 | US6310080 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 10/30/2001 | US6310074 Substituted dimeric compounds |
| 10/30/2001 | CA2123101C Nitroxyalkylamide derivative |
| 10/25/2001 | WO2001079157A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 10/25/2001 | WO2001078723A1 Compounds and methods |
| 10/25/2001 | WO2001049288A9 Novel compounds and compositions as protease inhibitors |
| 10/25/2001 | CA2406442A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 10/24/2001 | CN1319097A Benzoxazine and benzothiazine derivatives and their use in medicines |
| 10/24/2001 | CN1319007A Medical composition containing nitroetheneamine derivative or salt thereof as active constituent |
| 10/24/2001 | CN1318535A Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same |
| 10/23/2001 | US6306857 Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1′-yl propanones |
| 10/18/2001 | US20010031874 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |
| 10/18/2001 | US20010030312 Dopes for liquid crystals |
| 10/17/2001 | EP1146041A1 Derivatives of heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane and their use as inhibitors of the recapture of serotonine and of noradrenaline |
| 10/17/2001 | CN1317965A Compounds having IgE affecting properties |
| 10/17/2001 | CN1317478A Pure beta-hydroxyethoxyacetic acid salt, pure 2-p-dioxaneone, and prodn. method thereof |
| 10/16/2001 | US6303798 Perfumes, fragrance enhancers |
| 10/16/2001 | US6303796 Chemical intermediates; optically active compounds useful as optical resolution agents; metal-coordinated compounds useful as asymmetric catalysts |
| 10/16/2001 | US6303720 Olefin polymerization catalysts containing group 8-10 transition metals, processes employing such catalysts and polymers obtained therefrom |
| 10/10/2001 | EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 10/10/2001 | EP1140799A1 Novel propargylether derivatives |
| 10/10/2001 | CN1317002A Oxygenic heterocyclic compounds |
| 10/10/2001 | CN1072665C Preparation of unsaturated cyclic ethers |
| 10/04/2001 | WO2001072736A1 Method for purification of cyclic ester |
| 10/04/2001 | WO2001072706A1 Synthesis of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 10/04/2001 | WO2001021577A3 Melanin concentrating hormone antagonist |
| 10/04/2001 | US20010027172 Made by decarboxylation of the corresponding fluoroalkyl ether carboxylic acids; use in fluorinated polyether deposition, soldering, and cleaning and drying; low boiling, shorter atomospheric life, less harmful to ozone layer |
| 10/04/2001 | US20010025782 Process and apparatus for treating dioxins |
| 10/04/2001 | EP1138664A2 Purified salt of B-hydroxyethoxy acetic acid, 2-P-dioxanone, and manufacturing method therefor |
| 10/04/2001 | EP0841334B1 Process for producing 1,4-benzodioxane derivatives |
| 10/03/2001 | CN1072217C Process for producing 2-substituted-3,4-condensed heterocyclic benzoic acid |
| 10/02/2001 | US6297401 A 3-nitrosalicylamide derivative effective against plant pytopathogens |
| 10/02/2001 | US6297390 Amidation of methyl lactate, protecting free oh function with ethylvinylether, grignard reaction to produce the corresponding unsaturated ketone; reductive rearrangement, use as a perfume. |
| 10/02/2001 | US6297388 6-alkoxycarbonylmethyl-4h-1,3-dioxin-4-ones produced by reacting a 6-halomethyl-4h-1,3-dioxin-4-one with carbon monoxide, an alcohol or water, and 3-oxopentanedicarboxylic acid esters further produced by reacting above derivatives |
| 10/02/2001 | US6297260 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 09/27/2001 | WO2001070721A1 Method for purifying cyclic esters |
| 09/27/2001 | WO2001070720A2 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 09/27/2001 | WO2001070682A2 Carbocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | WO2001070677A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 09/27/2001 | US20010025105 Anticancer agent; Alzheimer's therapy |
| 09/27/2001 | US20010025007 Contacting one or more olefin monomers with a Group 8-10 transition metal complex catalyst and optionally a Bronsted or Lewis acid |
| 09/27/2001 | US20010024749 Surface modified carbonaceous materials |
| 09/27/2001 | DE10013507A1 New chiral 2,4,5-tri-substituted 1,3-dioxane compounds with mesogenic groups are used as chiral dopants for liquid crystal systems, e.g. for display, and polymerizable compositions for printing, coating or making e.g. pigment |
| 09/27/2001 | CA2404236A1 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 09/27/2001 | CA2403778A1 Carbocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | CA2403426A1 Method for purifying cyclic esters |
| 09/26/2001 | EP1136480A1 Process for the purification of cyclic esters |
| 09/26/2001 | EP1136479A1 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
| 09/26/2001 | EP1136478A2 Chiral 1,3-dioxane compounds |
| 09/26/2001 | EP0934252B1 Amide derivatives and their use as pesticides |
| 09/26/2001 | CN1314881A Imidamide derivatives |
| 09/25/2001 | US6294680 Process for the production of semi synthetic statins via novel intermediates |
| 09/20/2001 | WO2001068619A1 5-amide substituted diarylamines as mex inhibitors |
| 09/20/2001 | US20010023297 Amido compounds and process for producing the same |